Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience

被引：0
|
作者：
Cellerino, Maria [1 ]
Boffa, Giacomo [1 ]
Lapucci, Caterina [2 ]
Sbragia, Elvira [1 ]
Bruschi, Nicolo [1 ]
Mancuso, Elisabetta [1 ]
Tazza, Francesco [1 ]
Poire, Ilaria [3 ]
Laroni, Alice [3 ]
Capello, Elisabetta [3 ]
Uccelli, Antonio [1 ,3 ]
Novi, Giovanni [3 ]
Inglese, Matilde [1 ]
机构：
[1] Univ Genoa, DINOGMI, Genoa, Italy
[2] Lab Neurosci Sperimentali, Osped Policlin San Martino IRCCS, Genoa, Italy
[3] Dept Neurol, Osped Policlin San Martino IRCCS, Genoa, Italy
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2504
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Progressive ms patients of older age on ocrelizumab: real-world experience at columbia university irving medical center
    Epstein, S.
    Fong, K.
    De Jager, P.
    Riley, C.
    Levine, L.
    Vargas, W.
    Farber, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 299 - 299
  • [42] The real-world safety and effectiveness of ocrelizumab in patients with primary progressive multiple sclerosis - a confidence study interim analysis
    Buttmann, M.
    Meuth, S.
    Weber, M.
    Dirks, P.
    Eggebrecht, J.
    Hieke-Schulz, S.
    Leemhuis, J.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 386 - 387
  • [43] Real-World Experience with Ocrelizumab
    Moss, Brandon P.
    Utigard, Erica
    Baldassari, Laura E.
    Cohen, Jeffrey A.
    Ontaneda, Daniel D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 31 - 31
  • [44] Real-World Experience with Ocrelizumab
    Moss, Brandon
    Parrotta, Erica
    Baldassari, Laura
    Cohen, Jeffrey
    Ontaneda, Daniel
    NEUROLOGY, 2019, 92 (15)
  • [45] Findings from a large monocentric real-world experience of Ocrelizumab use in Multiple Sclerosis
    Mellino, Paolo
    Pilotto, Silvy
    Frau, Jessica
    Carmagnini, Daniele
    Coghe, Giancarlo
    Cocco, Eleonora
    Lorefice, Lorena
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 613 - 614
  • [46] Real world experience with Ocrelizumab in patients with primary progressive multiple sclerosis: insights from the German NeuroTransData Registry
    Braune, S.
    Bluemich, S.
    Bruns, C.
    Dirks, P.
    Hoffmann, J.
    Muros-Le Rouzic, E.
    Bergmann, A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 210 - 211
  • [47] Ocrelizumab in people with primary progressive sclerosis: a real-world multicentric study
    Skoric, Magdalena Krbot
    Kes, Vanja Basic
    Grbic, Nevena
    Lazibat, Ines
    Pavelin, Sanda
    Zubonja, Tea Mirosevic
    Komso, Milica
    Piskac, Spomenka Kidemet
    Abicic, Ana
    Adamec, Ivan
    Barun, Barbara
    Gabelic, Tereza
    Habek, Mario
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 657 - 657
  • [48] Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
    Chisari, Clara G.
    Bianco, Assunta
    Morra, Vincenzo Brescia
    Calabrese, Massimiliano
    Capone, Fioravante
    Cavalla, Paola
    Chiavazza, Carlotta
    Comi, Cristoforo
    Danni, Maura
    Filippi, Massimo
    Iaffaldano, Pietro
    Lanzillo, Roberta
    Lo Fermo, Salvatore
    Lucisano, Alessandra
    Lugaresi, Alessandra
    Lus, Giacomo
    Marfia, Gerolama Alessandra
    Marinelli, Fabiana
    Mirabella, Massimiliano
    Moiola, Lucia
    Perin, Chiara
    Realmuto, Sabrina
    Toscano, Simona
    Trojano, Maria
    Vecchio, Domizia
    Patti, Francesco
    NEUROTHERAPEUTICS, 2023, 20 (06) : 1696 - 1706
  • [49] Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
    Clara G. Chisari
    Assunta Bianco
    Vincenzo Brescia Morra
    Massimiliano Calabrese
    Fioravante Capone
    Paola Cavalla
    Carlotta Chiavazza
    Cristoforo Comi
    Maura Danni
    Massimo Filippi
    Pietro Iaffaldano
    Roberta Lanzillo
    Salvatore Lo Fermo
    Alessandra Lucisano
    Alessandra Lugaresi
    Giacomo Lus
    Gerolama Alessandra Marfia
    Fabiana Marinelli
    Massimiliano Mirabella
    Lucia Moiola
    Chiara Perin
    Sabrina Realmuto
    Simona Toscano
    Maria Trojano
    Domizia Vecchio
    Francesco Patti
    Neurotherapeutics, 2023, 20 (6) : 1696 - 1706
  • [50] Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience
    Marwan Sheikh-Taha
    American Journal of Cardiovascular Drugs, 2019, 19 : 59 - 64
12345